{"name":"Psoriasis Treatment Center of Central New Jersey","slug":"psoriasis-treatment-center-of-central-new-jersey","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Enstilar 0.005%-0.064% Topical Foam","genericName":"Enstilar 0.005%-0.064% Topical Foam","slug":"enstilar-0-005-0-064-topical-foam","indication":"Plaque psoriasis in adults","status":"marketed"},{"name":"Topicort Topical Spray","genericName":"Topicort Topical Spray","slug":"topicort-topical-spray","indication":"Psoriasis","status":"marketed"},{"name":"Ilumya Injectable Product","genericName":"Ilumya Injectable Product","slug":"ilumya-injectable-product","indication":"Moderate to severe plaque psoriasis","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Ameluz 10% Topical Gel","genericName":"Ameluz 10% Topical Gel","slug":"ameluz-10-topical-gel","indication":"Actinic keratosis (field treatment)","status":"marketed"}]}],"pipeline":[{"name":"Enstilar 0.005%-0.064% Topical Foam","genericName":"Enstilar 0.005%-0.064% Topical Foam","slug":"enstilar-0-005-0-064-topical-foam","phase":"marketed","mechanism":"Enstilar combines a potent corticosteroid (betamethasone dipropionate) and a vitamin D analog (calcipotriene) to reduce inflammation and normalize skin cell differentiation in psoriasis.","indications":["Plaque psoriasis in adults"],"catalyst":""},{"name":"Topicort Topical Spray","genericName":"Topicort Topical Spray","slug":"topicort-topical-spray","phase":"marketed","mechanism":"Topicort (desoximetasone) is a topical corticosteroid that reduces inflammation and suppresses immune responses in the skin.","indications":["Psoriasis","Dermatitis","Eczema","Other inflammatory skin conditions responsive to topical corticosteroids"],"catalyst":""},{"name":"Ameluz 10% Topical Gel","genericName":"Ameluz 10% Topical Gel","slug":"ameluz-10-topical-gel","phase":"marketed","mechanism":"Ameluz is a topical photodynamic therapy agent that generates reactive oxygen species upon light activation to destroy abnormal skin cells.","indications":["Actinic keratosis (field treatment)","Basal cell carcinoma (superficial and nodular)"],"catalyst":""},{"name":"Ilumya Injectable Product","genericName":"Ilumya Injectable Product","slug":"ilumya-injectable-product","phase":"marketed","mechanism":"Ilumya (tildrakizumab) is a monoclonal antibody that selectively blocks the IL-23 pathway by binding to the p19 subunit of interleukin-23, reducing inflammatory signaling in psoriasis.","indications":["Moderate to severe plaque psoriasis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1xcTV0QTQzZnhuNVBZSXU5VGRaekdFWTlnbzlJYXNkSmJKREE4VDBOUHdFN1E2WXVvdjUzTEJMNnpLa180UURPWTJlN2RvWVMwTmRmNzZyYkFXRTE1UU93?oc=5","date":"2025-08-27","type":"pipeline","source":"nature.com","summary":"A psoriasis cure could be in touching distance - nature.com","headline":"A psoriasis cure could be in touching distance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPQ2N3RjB2b3l6RXlQZ2hLVUV5Q2hib19PeU9hbjBiM3BYX2ZRNWJPM0hoQlROZXNpMXB3OGZ6bWZxaV92dGdlbk9aZTZtYVpLdHlBd3lLNmo1MnBEd1h1RFFoV09oXzE3dHF2Tk5CeFJFRy10WE0tRGFYTTRqVE4zblYxUlo3c3lGRmJNa2kzLWFRZXhRamJOS2ZwOF8zWlozNDYzNzQzcTk3VHhWMVVCQ0M3RQ?oc=5","date":"2023-02-11","type":"pipeline","source":"Healio","summary":"Dupixent shows consistent, long-term efficacy in real-world studies - Healio","headline":"Dupixent shows consistent, long-term efficacy in real-world studies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE42NzQwLXZhOG1JcWtqclZ1WFdkVlZlOC1ZUHdjTVkwX185aUYtMnl3Z2dpYVM1WGY4eHBDS2FTT1hsdkNKbDRpaDd5UzBOM1BGMHdYQ19DbXpHYTJGVnJZM2xJcXNIc0tfaVE?oc=5","date":"2022-01-04","type":"trial","source":"Wiley Online Library","summary":"Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial* - August","headline":"Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPRmYwd0lTOTVtTU1RazhfbXRqdmVldkhwNWhTSUJxQTl3U19hU1pTV1FqQ1REYVI1ZzgxRXJ6aVhwNWE5aTQ0YnVudTI5XzNId0M4ekpKdWNkNGZXT0R3VHE4THg2U040M0g1aXlRVUQ3RDlUU2JWTkVRdTU4T1BXdWd4VmJvXzYzTGtVYmN3bGFJdU9RT0RaYTVoWQ?oc=5","date":"2021-07-12","type":"patent","source":"Fierce Pharma","summary":"The top 15 blockbuster patent expirations coming this decade - Fierce Pharma","headline":"The top 15 blockbuster patent expirations coming this decade","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQZW1UTXk5UTd1WEJDZVRES2hfY2VNbHhrRjRIMFBHVG5MOU14TmtLOWxJWHd4UEZaTlk2cTVVZGE1TWF6M0NSSy1Db1JWNFJjeUdRcTBkejNES2JlaHVfYTZyVDlhM1BYb2dOUURfTm5hQ0tnTlhFaUg0TUZUUmdMa3dPRXhmUy1TTkp0cEk4cUpEa25xMlB3Vk9acm9SR2t1MkxZUGF5X1lPbzFhS1JQczVB?oc=5","date":"2021-02-10","type":"pipeline","source":"Healio","summary":"Bimekizumab shows rapid, effective treatment of plaque psoriasis - Healio","headline":"Bimekizumab shows rapid, effective treatment of plaque psoriasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPd0ZRTFZaUjBNa3c5T0N3S3hxbElZYzFJX1ZzMU9WMlZ3NThPSnpBVjdoQ2RmV29EUE9KQlhxbERuSUNacW5XU2h4cDdLZ1pPNU9xR3AzNHB6V0pRVGRCbHVUaV92YjdoNGQyb0lKWjNlSHhiSExYNkd6dGJSd3QwbnJiOFBNa0luTUd0QXlLdHNaOXpULXRwQ19odmFYbFR5Q0owZkFFeWlGUnBQV29IZm1xdGhDcmZGWDJQZkQwT09zMjZ1Z2Jn?oc=5","date":"2020-08-06","type":"pipeline","source":"Healio","summary":"Flexible, Personalized Care Needed for Psoriatic Disease During COVID-19 Pandemic - Healio","headline":"Flexible, Personalized Care Needed for Psoriatic Disease During COVID-19 Pandemic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5mdE83MlFwdlYzY0pzNmxaQU9rY2labnBnMTdiSTkydjh2SnRfN1ZPb0poV0JzQ3VhMnROZlBIUkZnRENVb3NUUUo1M1o3bkt6TGxNV2VFcFA3OUZyMmpMNW5UM1pFMi1UUS01ZG9Bd1FnUDBCc0EtWnRNY0I?oc=5","date":"2019-12-18","type":"pipeline","source":"HealthCentral","summary":"How Dry Am I? How Weather Affects Your Psoriasis - HealthCentral","headline":"How Dry Am I? How Weather Affects Your Psoriasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE83TzNMUko1YUJRd0ppZHZtY2dIZ2JaUml4bVpNNTVhRmROekQzTUZFRXlCelAxTS05d1pGeVJ2MGJFck02b2o0RE9ia1l2V0VSTGtCMG5XLVdGWm1OMGo0?oc=5","date":"2018-05-01","type":"pipeline","source":"NEJM","summary":"Etanercept as Monotherapy in Patients with Psoriasis - NEJM","headline":"Etanercept as Monotherapy in Patients with Psoriasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNX0xzSl9PU2pqZlktcU9VTm1PT2ZGVGpSMWo4QzdxaGpKVWU5VUhIUVNpQ3NYdnFETS13RkZPd3VlY2VBcV9YdXA2WFVfZzVUeGE0UWc4cXFzSXJkY204RzFpNlF2YUxtY2M2Z3JBd2d1MXppdHV1RkRsa0owaUoySUVCQk9JQjJ1cnR4a3plSUZzZVVNZ3dMdUpwV1BqNFpLTm84M0EtTUZFY1VrS0ItSl8wak43eXFaSUdsakFKZTZnTDh6U0ZvRjJWc2w?oc=5","date":"2016-10-12","type":"pipeline","source":"dovepress.com","summary":"Usability of a novel disposable autoinjector device for ixekizumab | MDER - dovepress.com","headline":"Usability of a novel disposable autoinjector device for ixekizumab | MDER","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxOaGhZV1BubEJvN0pVM0p3QThUN0xXSUdlRUdoNXBncE9DRjNjUjNpcnFoNExMbnVpWnFNbnFTT09jc1d3b0R1b2gyNF9rQnplb3d3RElITWJNMU9FbjhrLS1LVFJjSFFuaEtFUzVLYlY3TnA2aVhmUmR3U2VvRFFHS3FZNUlvMmlDTHdfQnFHQ3JleFpENzZOcnhjdmRmUVpub29QcnE2U3ZGNVNaSVMyUWtBdEY2d2dkQlZSTHAtUExPdmJ6b0xhZ2tfQ2p1RHE0LW1JTXQ1cVpXZzY3M0JOS0JaUjVEY01TMXNwMkdMX2g5dTdPdWhGLUZuMA?oc=5","date":"2011-02-04","type":"pipeline","source":"PR Newswire","summary":"Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis - PR Newswire","headline":"Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"marketed":4},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}